환자 참여 솔루션 시장 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

Persistence Market Research has recently published an extensive report on the global Patient Engagement Solution Market. This report provides an in-depth analysis of essential market dynamics, including drivers, trends, opportunities, and challenges, offering valuable insights into the market landscape.

Key Insights:

• Patient Engagement Solution Market Size (2024E): USD 21.3 Bn
• Projected Market Value (2033F): USD 50.7 Bn
• Global Market Growth Rate (CAGR 2024 to 2033): 13.2%

Patient Engagement Solution Market - Report Scope:

Patient engagement solutions represent a significant advancement in healthcare, focusing on improving patient participation in their own care. These solutions encompass a range of tools and technologies designed to facilitate communication between patients and healthcare providers, enhance patient education, and improve overall healthcare outcomes. The market includes platforms such as patient portals, mobile health apps, and remote monitoring systems. The growth of the patient engagement market is driven by the increasing emphasis on patient-centered care, advancements in digital health technologies, and the need for improved healthcare outcomes.

Market Growth Drivers:

The global patient engagement solution market is driven by several key factors, including the rising demand for personalized and patient-centered healthcare services. Technological advancements in digital health, such as telemedicine, mobile health applications, and wearable devices, are enhancing patient engagement and driving market expansion. Increased focus on chronic disease management and preventive care is also contributing to market growth, as these solutions enable better monitoring and management of health conditions. Additionally, supportive government initiatives and healthcare reforms aimed at improving patient care and outcomes are further propelling the adoption of patient engagement solutions.

Market Restraints:

Despite its growth potential, the patient engagement solution market faces challenges related to data security, privacy concerns, and technological integration. Ensuring the security and privacy of patient data is crucial for maintaining trust and compliance with regulations such as HIPAA. The integration of patient engagement solutions with existing healthcare systems can be complex and costly, posing a challenge for healthcare providers. Additionally, disparities in digital health literacy and access to technology among different patient populations may hinder the widespread adoption of these solutions.

Market Opportunities:

The patient engagement solution market offers substantial growth opportunities driven by technological innovations and evolving healthcare models. The integration of artificial intelligence (AI) and machine learning into patient engagement platforms can enhance personalized care and predictive analytics. Opportunities also exist in expanding these solutions to underserved and rural areas, where access to healthcare services may be limited. Strategic partnerships between technology providers, healthcare organizations, and payers can create new business models and drive market growth. Additionally, the growing focus on value-based care and patient satisfaction presents opportunities for developing innovative patient engagement solutions.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the patient engagement solution market globally?
• Which types of patient engagement solutions are gaining traction in different regions?
• How are technological advancements reshaping the competitive landscape of the patient engagement market?
• Who are the key players contributing to the patient engagement solution market, and what strategies are they employing to maintain market relevance?
• What are the emerging trends and future prospects in the global patient engagement solution market?

Competitive Intelligence and Business Strategy:

Key players in the global patient engagement solution market, including companies such as Cerner Corporation, Allscripts Healthcare Solutions, and Medisafe, focus on innovation, product differentiation, and strategic partnerships to gain a competitive edge. These companies invest in R&D to develop advanced patient engagement tools, enhance interoperability with existing healthcare systems, and improve user experience. Collaborations with healthcare providers, technology firms, and regulatory bodies are essential to drive market adoption and address emerging needs. Additionally, a focus on data security, integration capabilities, and customer support helps to foster market growth and ensure the successful implementation of patient engagement solutions.

Key Companies Profiled:

• Allscripts Healthcare Solutions
• Mckesson Corporation
• Cerner Corporation
• Phytel Inc
• Medecision Inc
• Athenahealth Inc
• Novartis
• Roche Holding AG
• Bayer
• GlaxoSmithkline
• IQVIA

Key Segments of Patient Engagement Solution Market Industry Research

By Solution:

• Software
• Services

By Deployment:

• Cloud
• On Premise

By Application:

• Health Management
• Social Management
• Home Healthcare Management
• Financial Health Management

By End User:

• Patients
• Payers
• Healthcare Providers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia Pacific
• Middle East and Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Pricing Analysis

• 4.1. Pricing Analysis, By Solution
  • 4.1.1. Subscription Pricing Model
  • 4.1.2. Perpetual Licensing
• 4.2. Average Pricing Analysis Benchmark

5. Global Patient Engagement Solution Market Demand (in Value in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

• 5.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
• 5.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
  • 5.2.1. Y-o-Y Growth Trend Analysis
  • 5.2.2. Absolute $ Opportunity Analysis

6. Market Background

• 6.1. Macro-Economic Factors
• 6.2. Forecast Factors - Relevance & Impact
• 6.3. Value Chain
• 6.4. COVID-19 Crisis - Impact Assessment
  • 6.4.1. Current Statistics
  • 6.4.2. Short-Mid-Long Term Outlook
  • 6.4.3. Likely Rebound
• 6.5. Market Dynamics
  • 6.5.1. Drivers
  • 6.5.2. Restraints
  • 6.5.3. Opportunities

7. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Solution

• 7.1. Introduction / Key Findings
• 7.2. Historical Market Size (US$ Bn) Analysis By Solution, 2019-2023
• 7.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Solution, 2024-2033
  • 7.3.1. Software
    • 7.3.1.1. Integrated Patient Engagement Software
    • 7.3.1.2. Standalone Software
      • 7.3.1.2.1. Scheduling Software
      • 7.3.1.2.2. Billing Software
      • 7.3.1.2.3. Secure Messaging Software
      • 7.3.1.2.4. Others
  • 7.3.2. Services
    • 7.3.2.1. Implementation and Integration
    • 7.3.2.2. Consulting
    • 7.3.2.3. Support and Maintenance
• 7.4. Market Attractiveness Analysis By Solution

8. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Deployment

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Bn) Analysis By Deployment, 2019-2023
• 8.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Deployment, 2024-2033
  • 8.3.1. Cloud
  • 8.3.2. On-Premise
• 8.4. Market Attractiveness Analysis By Deployment

9. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Bn) Analysis By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Application, 2024-2033
  • 9.3.1. Health Management
  • 9.3.2. Social Management
  • 9.3.3. Home Healthcare Management
  • 9.3.4. Financial Health Management
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Application

10. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Bn) Analysis By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By End User, 2024-2033
  • 10.3.1. Patients
  • 10.3.2. Payers
  • 10.3.3. Healthcare Providers
  • 10.3.4. Others
• 10.4. Market Attractiveness Analysis By End User

11. Global Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033, by Region

• 11.1. Introduction / Key Findings
• 11.2. Historical Market Size (US$ Bn) Analysis By Region, 2019-2023
• 11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia Pacific
  • 11.3.6. Middle East and Africa
• 11.4. Market Attractiveness Analysis By Region

12. North America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 12.3.1. By Solution
  • 12.3.2. By Deployment
  • 12.3.3. By Application
  • 12.3.4. By End User
  • 12.3.5. By Country
    • 12.3.5.1. U.S.
    • 12.3.5.2. Canada
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Solution
  • 12.4.2. By Deployment
  • 12.4.3. By Application
  • 12.4.4. By End User
  • 12.4.5. By Country
• 12.5. Market Trends
• 12.6. Key Market Participants - Intensity Mapping

13. Latin America Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Solution
  • 13.3.2. By Deployment
  • 13.3.3. By Application
  • 13.3.4. By End User
  • 13.3.5. By Country
    • 13.3.5.1. Brazil
    • 13.3.5.2. Mexico
    • 13.3.5.3. Rest of Latin America
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Solution
  • 13.4.2. By Deployment
  • 13.4.3. By Application
  • 13.4.4. By End User
  • 13.4.5. By Country

14. Europe Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Solution
  • 14.3.2. By Deployment
  • 14.3.3. By Application
  • 14.3.4. By End User
  • 14.3.5. By Country
    • 14.3.5.1. Germany
    • 14.3.5.2. Italy
    • 14.3.5.3. France
    • 14.3.5.4. U.K.
    • 14.3.5.5. Spain
    • 14.3.5.6. BENELUX
    • 14.3.5.7. Russia
    • 14.3.5.8. Rest of Europe
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Solution
  • 14.4.2. By Deployment
  • 14.4.3. By Application
  • 14.4.4. By End User
  • 14.4.5. By Country

15. South Asia & Pacific Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Solution
  • 15.3.2. By Deployment
  • 15.3.3. By Application
  • 15.3.4. By End User
  • 15.3.5. By Country
    • 15.3.5.1. India
    • 15.3.5.2. Indonesia
    • 15.3.5.3. Malaysia
    • 15.3.5.4. Singapore
    • 15.3.5.5. Australia & New Zealand
    • 15.3.5.6. Rest of South Asia and Pacific
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Solution
  • 15.4.2. By Deployment
  • 15.4.3. By Application
  • 15.4.4. By End User
  • 15.4.5. By Country

16. East Asia Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Solution
  • 16.3.2. By Deployment
  • 16.3.3. By Application
  • 16.3.4. By End User
  • 16.3.5. By Country
    • 16.3.5.1. China
    • 16.3.5.2. Japan
    • 16.3.5.3. South Korea
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Solution
  • 16.4.2. By Deployment
  • 16.4.3. By Application
  • 16.4.4. By End User
  • 16.4.5. By Country

17. Middle East and Africa Patient Engagement Solution Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Solution
  • 17.3.2. By Deployment
  • 17.3.3. By Application
  • 17.3.4. By End User
  • 17.3.5. By Country
    • 17.3.5.1. GCC Countries
    • 17.3.5.2. Turkey
    • 17.3.5.3. South Africa
    • 17.3.5.4. Rest of Middle East and Africa
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Solution
  • 17.4.2. By Deployment
  • 17.4.3. By Application
  • 17.4.4. By End User
  • 17.4.5. By Country

18. Key Countries Analysis- Patient Engagement Solution Market

• 18.1. U.S. Patient Engagement Solution Market Analysis
  • 18.1.1. By Solution
  • 18.1.2. By Deployment
  • 18.1.3. By Application
  • 18.1.4. By End User
• 18.2. Canada Patient Engagement Solution Market Analysis
  • 18.2.1. By Solution
  • 18.2.2. By Deployment
  • 18.2.3. By Application
  • 18.2.4. By End User
• 18.3. Mexico Patient Engagement Solution Market Analysis
  • 18.3.1. By Solution
  • 18.3.2. By Deployment
  • 18.3.3. By Application
  • 18.3.4. By End User
• 18.4. Brazil Patient Engagement Solution Market Analysis
  • 18.4.1. By Solution
  • 18.4.2. By Deployment
  • 18.4.3. By Application
  • 18.4.4. By End User
• 18.5. Germany Patient Engagement Solution Market Analysis
  • 18.5.1. By Solution
  • 18.5.2. By Deployment
  • 18.5.3. By Application
  • 18.5.4. By End User
• 18.6. Italy Patient Engagement Solution Market Analysis
  • 18.6.1. By Solution
  • 18.6.2. By Deployment
  • 18.6.3. By Application
  • 18.6.4. By End User
• 18.7. France Patient Engagement Solution Market Analysis
  • 18.7.1. By Solution
  • 18.7.2. By Deployment
  • 18.7.3. By Application
  • 18.7.4. By End User
• 18.8. U.K. Patient Engagement Solution Market Analysis
  • 18.8.1. By Solution
  • 18.8.2. By Deployment
  • 18.8.3. By Application
  • 18.8.4. By End User
• 18.9. Spain Patient Engagement Solution Market Analysis
  • 18.9.1. By Solution
  • 18.9.2. By Deployment
  • 18.9.3. By Application
  • 18.9.4. By End User
• 18.10. BENELUX Patient Engagement Solution Market Analysis
  • 18.10.1. By Solution
  • 18.10.2. By Deployment
  • 18.10.3. By Application
  • 18.10.4. By End User
• 18.11. Russia Patient Engagement Solution Market Analysis
  • 18.11.1. By Solution
  • 18.11.2. By Deployment
  • 18.11.3. By Application
  • 18.11.4. By End User
• 18.12. Rest of Europe Patient Engagement Solution Market Analysis
  • 18.12.1. By Solution
  • 18.12.2. By Deployment
  • 18.12.3. By Application
  • 18.12.4. By End User
• 18.13. China Patient Engagement Solution Market Analysis
  • 18.13.1. By Solution
  • 18.13.2. By Deployment
  • 18.13.3. By Application
  • 18.13.4. By End User
• 18.14. Japan Patient Engagement Solution Market Analysis
  • 18.14.1. By Solution
  • 18.14.2. By Deployment
  • 18.14.3. By Application
  • 18.14.4. By End User
• 18.15. South Korea Patient Engagement Solution Market Analysis
  • 18.15.1. By Solution
  • 18.15.2. By Deployment
  • 18.15.3. By Application
  • 18.15.4. By End User
• 18.16. India Patient Engagement Solution Market Analysis
  • 18.16.1. By Solution
  • 18.16.2. By Deployment
  • 18.16.3. By Application
  • 18.16.4. By End User
• 18.17. Malaysia Patient Engagement Solution Market Analysis
  • 18.17.1. By Solution
  • 18.17.2. By Deployment
  • 18.17.3. By Application
  • 18.17.4. By End User
• 18.18. Indonesia Patient Engagement Solution Market Analysis
  • 18.18.1. By Solution
  • 18.18.2. By Deployment
  • 18.18.3. By Application
  • 18.18.4. By End User
• 18.19. Singapore Patient Engagement Solution Market Analysis
  • 18.19.1. By Solution
  • 18.19.2. By Deployment
  • 18.19.3. By Application
  • 18.19.4. By End User
• 18.20. Australia and New Zealand Patient Engagement Solution Market Analysis
  • 18.20.1. By Solution
  • 18.20.2. By Deployment
  • 18.20.3. By Application
  • 18.20.4. By End User
• 18.21. GCC Countries Patient Engagement Solution Market Analysis
  • 18.21.1. By Solution
  • 18.21.2. By Deployment
  • 18.21.3. By Application
  • 18.21.4. By End User
• 18.22. Turkey Patient Engagement Solution Market Analysis
  • 18.22.1. By Solution
  • 18.22.2. By Deployment
  • 18.22.3. By Application
  • 18.22.4. By End User
• 18.23. South Africa Patient Engagement Solution Market Analysis
  • 18.23.1. By Solution
  • 18.23.2. By Deployment
  • 18.23.3. By Application
  • 18.23.4. By End User
• 18.24. Rest of Middle East and Africa Patient Engagement Solution Market Analysis
  • 18.24.1. By Solution
  • 18.24.2. By Deployment
  • 18.24.3. By Application
  • 18.24.4. By End User

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Benchmarking
• 20.3. Competition Deep Dive
  • 20.3.1. Allscripts Healthcare Solutions
    • 20.3.1.1. Business Overview
    • 20.3.1.2. Product Portfolio
    • 20.3.1.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.1.4. Key Strategy & Developments
  • 20.3.2. Mckesson Corporation
    • 20.3.2.1. Business Overview
    • 20.3.2.2. Product Portfolio
    • 20.3.2.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.2.4. Key Strategy & Developments
  • 20.3.3. Cerner Corporation
    • 20.3.3.1. Business Overview
    • 20.3.3.2. Product Portfolio
    • 20.3.3.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.3.4. Key Strategy & Developments
  • 20.3.4. Phytel Inc
    • 20.3.4.1. Business Overview
    • 20.3.4.2. Product Portfolio
    • 20.3.4.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.4.4. Key Strategy & Developments
  • 20.3.5. Medecision Inc
    • 20.3.5.1. Business Overview
    • 20.3.5.2. Product Portfolio
    • 20.3.5.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.5.4. Key Strategy & Developments
  • 20.3.6. Athenahealth Inc
    • 20.3.6.1. Business Overview
    • 20.3.6.2. Product Portfolio
    • 20.3.6.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.6.4. Key Strategy & Developments
  • 20.3.7. Novartis
    • 20.3.7.1. Business Overview
    • 20.3.7.2. Product Portfolio
    • 20.3.7.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.7.4. Key Strategy & Developments
  • 20.3.8. Roche Holding AG
    • 20.3.8.1. Business Overview
    • 20.3.8.2. Product Portfolio
    • 20.3.8.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.8.4. Key Strategy & Developments
  • 20.3.9. Bayer
    • 20.3.9.1. Business Overview
    • 20.3.9.2. Product Portfolio
    • 20.3.9.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.9.4. Key Strategy & Developments
  • 20.3.10. GlaxoSmithkline
    • 20.3.10.1. Business Overview
    • 20.3.10.2. Product Portfolio
    • 20.3.10.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.10.4. Key Strategy & Developments
  • 20.3.11. IQVIA
    • 20.3.11.1. Business Overview
    • 20.3.11.2. Product Portfolio
    • 20.3.11.3. Profitability by Market Segments (Business Segments/Region)
    • 20.3.11.4. Key Strategy & Developments

21. Assumptions and Acronyms Used

22. Research Methodology